The Center for Advanced Biological Innovation & Manufacturing (CABIM) seeks a chief executive officer. A collaboration among leading research institutions, industry, and major teaching hospitals, CABIM is expected to explore and catalyze innovations in cell and gene therapy, advance biologic innovation and manufacturing, and accelerate developments in immunotherapy, cell therapies, gene editing, and other technologies that carry the promise of lasting impact on human health globally. Reporting to a Board of Directors, the chief executive officer will have responsibility for site construction and management, manufacturing, stakeholder relations, and business development, among other duties.
To address the bottleneck in the discovery pipeline in immunotherapies and other emerging medicines, leaders from Harvard University, Massachusetts Institute of Technology (MIT), Fujifilm Diosynth Biotechnologies (FDB), GE Healthcare Life Sciences, and Alexandria Real Estate Equities came together as a consortium to create CABIM. Joining these organizations as contributing members are Beth Israel Deaconess Medical Center, Boston Children's Hospital, Brigham and Women's Hospital, the Dana-Farber Cancer Institute, Massachusetts General Hospital, MilliporeSigma, and the Commonwealth of Massachusetts.
The overarching mission of CABIM is to catalyze the development of transformative therapies by shortening the path between research and clinical application. CABIM will serve its stakeholders by harnessing world-leading expertise to propel forward fast-emerging and promising science, the cost and risks of which are daunting for any single institution to tackle alone. By housing institutions with strengths in each link in the
Candidates must have a minimum of 15 years of experience working in academic, research, or industry environments, preferably including the setting up new initiatives or ventures. They should have a minimum five years of experience in a technical and operational role relevant to CABIM's mission. A minimum of five years of experience in a senior level leadership role. Advanced degree in medicine/life sciences and/or MBA required.
They should be fact-driven, proactive and effective decision-makers with the willingness to resolve and make difficult decisions. Additional key qualifications of candidates include:
Understanding of the pharma/biotech industry, venture capital, and technology translation;
Knowledge of cGMP operations and manufacturing and the US regulatory environment;
Ability to serve as part of a leadership team characterized by trust, open communication, and shared goals;
Ability to build collaborative relationships successfully with multiple constituencies and within complex and innovative structures;
Experience in driving strategic resource planning and budgeting, operations and risk management;
Success in recruiting, developing, and retaining a diverse, equitable, inclusive, and high- performing workforce;
Excellent networking and communication skills, written and verbal;
Unquestioned integrity, work ethic and trustworthiness.
EQUAL OPPORTUNITY EMPLOYER: We are an equal opportunity employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, or any other characteristic protected by law.
Internal Number: 52566BR
About Harvard University Administration
Harvard University is devoted to excellence in teaching, learning, and research, and to developing leaders in many disciplines who make a difference globally. The University, which is based in Cambridge and Boston, Massachusetts, has an enrollment of over 20,000 degree candidates, including undergraduate, graduate, and professional students. Harvard has more than 360,000 alumni around the world. The University has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a truly global education. Established in 1636, Harvard is the oldest institution of higher education in the United States.